The Inscripta™ Blog
May 4, 2021
Inside Inscripta: Laura Klitten, Commercial Operations EMEA Department/Group
Our employee profile series continues, this time with Laura Klitten, Scientific Liaison for the EMEA region. She earned her PhD in human/medical…
April 13, 2021
Video: Inscripta Customers Describe Their Experience with the Onyx Platform
By now you may have heard about our automated benchtop Onyx™ genome engineering platform — but have you seen it in action?
April 7, 2021
Inside Inscripta: Katherine Krouse, Applications
When it comes to technology development, one of the most important elements is understanding how customers will use it. That’s why we rely on…
March 30, 2021
Interested in Joining the Inscripta Team? We’re Hiring!
The Inscripta family is growing — fast. Our startup company is based on the idea that automating and scaling the CRISPR gene editing process…
March 26, 2021
Meet Infinome, the Newest Member of the Inscripta Family
We’re excited to announce that Inscripta now has its very first subsidiary company. We have invested in Infinome, a synthetic biology product…
March 23, 2021
Inscripta Expands Operations with New Office and Association Membership in Europe
Exciting news: Inscripta is heading to Europe! We are expanding operations beyond our U.S. base with a new office in Copenhagen, Denmark, to…
March 16, 2021
A New Digital Experience for Genome Engineering
As we designed the Onyx™ platform for automated genome engineering, we challenged ourselves to break free from the usual instrumentation and…
March 9, 2021
Scientists Deploy MAD7 Enzyme for Mammalian Genome Edits
Even before we launched our benchtop Onyx™ platform for automated genome engineering, the Inscripta team had already made progress in addressing…
March 2, 2021
Inside Inscripta: Patrick Westfall, Microbe
As we continue profiling members of the Inscripta team, we’re delighted to chat with Patrick Westfall, Senior Director, Microbe. The Illinois…